PharVision Advisers’s Lumentum LITE Stock Holding History

PharVision Advisers’s Portfolio LITE Stock Details LITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,445	Closed	-$533K	–	404
2025 Q4	$533K	Buy	+1,445	New	+$371K	0.27%	28

Other funds holding LITE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WAM

WT Asset Management Hong Kong $5.05B AUM 589.49% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

PharVision Advisers's LITE Position: Q1 2026 in Review

PharVision Advisers sold out of Lumentum (LITE) in Q1 2026, closing a stake of 1,445 shares — an estimated $533K sold.

PharVision Advisers first reported a position in LITE in Q4 2025 and held it in 1 quarter. The position peaked at $533K in Q4 2025. 1,089 funds tracked by Wall St. Rank hold LITE as of Q1 2026.

PharVision Advisers reported no remaining Lumentum position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,445 Lumentum shares in Q1 2026, an estimated $533K.
PharVision Advisers first reported a position in Lumentum in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Lumentum position peaked at $533K in Q4 2025.
1,089 funds tracked by Wall St. Rank held Lumentum as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.